Zydus Seeks DCGI Approval For Clinical Trial Of Monoclonal Antibodies Cocktail ...Middle East

New Delhi:  Zydus Cadila on Thursday announced that its biological therapy ZRC-3308, a cocktail of two SARS-CoV-2-neutralizing monoclonal antibodies (mAbs) can emerge as one of the main treatments for mild COVID-19. SARS-CoV-2 spike protein targeted, neutralizing monoclonal antibody based treatments have received emergency use authorization in mild COVID cases in the US, Europe and in […] The post Zydus Seeks DCGI Approval For Clinical Trial Of Monoclonal Antibodies Cocktail appeared first on Ommcom News.

Hence then, the article about zydus seeks dcgi approval for clinical trial of monoclonal antibodies cocktail was published today ( Thursday 27/05/2021 - 11:01 AM ) and is available on Ommcom News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Zydus Seeks DCGI Approval For Clinical Trial Of Monoclonal Antibodies Cocktail )

Also on site :

• UK to list 65-year-olds as reservists amid Russia threat claims – Telegraph
• Gaza plan phase two: US to discuss Hamas disarmament, Israeli withdrawal
• AI boom fuels fears of an industry bubble (VIDEO)